In the dynamic and rapidly expanding cannabis industry, growers serve as the backbone of the supply chain, responsible for cultivating high-quality cannabis products while adhering to a complex web of laws and regulations. From licensing requirements to cultivation practices, growers must navigate a range of regulatory challenges to operate legally and ethically. This article provides…
In the rapidly expanding cannabis industry, cannabis brokers serve as essential intermediaries between cultivators, manufacturers, distributors, and retailers, facilitating transactions and ensuring compliance with regulatory requirements. As with any industry, the cannabis sector is subject to a complex framework of laws and regulations that cannabis brokers must navigate to operate legally and ethically. This article…
In the burgeoning cannabis industry, budtenders play a crucial role as frontline ambassadors for dispensaries and cannabis retailers. However, with the legalization of cannabis comes a complex web of laws and regulations that budtenders must navigate to ensure compliance and uphold industry standards. This article aims to provide an in-depth overview of the laws and…
In recent years, the landscape of cannabis laws and regulations has undergone significant changes, particularly with the emergence of compounds like Delta-8-tetrahydrocannabinol (Delta-8-THC) and tetrahydrocannabinolic acid (THC-a). Understanding the legal framework surrounding the sale of these compounds is crucial for businesses and consumers alike. Delta-8-THC: A Legal Gray Area Delta-8-THC has gained popularity due to…
1. What are cannabis and marijuana? A. Cannabis is a plant of the Cannabaceae family and contains more than eighty biologically active chemical compounds. The most commonly known compounds are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Parts of the Cannabis sativa plant have been controlled under the Controlled Substances Act (CSA) since 1970 under the drug…
Testimony of Amy Abernethy, MD, PhD.Principal Deputy Commissioner – Office of the Commissioner Before the United States Senate Testimony of Amy Abernethy, Md, Phd., Principal Deputy Commissioner, Office of the Commissioner, Food and Drug Administration, Department of Health And Human Servicesbefore the Senate Committee on Agriculture, Nutrition, and Forestry July 25, 2019 Introduction Good morning,…
